Sun Pharma Announces the Availability of UNLOXCYT™ (cosibelimab-ipdl) for Advanced Cutaneous Squamous Cell Carcinoma (aCSCC)
Read More
Sun Pharma introduces its global innovative drug, Ilumya® in India for treatment of moderate-to-severe Plaque Psoriasis
Read More
FDA approves label update for UNLOXCYT™ (cosibelimab-ipdl) based on longer-term data that demonstrated improved clinical outcomes in advanced cutaneous squamous cell carcinoma (aCSCC)
Read More
Recent Comments